dihexa clinical trial human Capsules 10mg for Research Dihexa — the peptide that
Description
AstraZeneca Lead assets: Elecoglipron, an oral GLP-1RA candidate Metabolic focus: Obesity, overweight, type 2 diabetes and cardiometabolic disease AstraZeneca is developing elecoglipron as a once-daily GLP-1RA pill for obesity and type 2 diabetes
Several things may happen depending on the judgment
If you would like to request a 1-1 consultation, click HERE
The process takes just a few minutes, and there is no downtime, allowing you to continue your day immediately afterward
